Medidata has launched the Medidata Site Insights Program, aimed at expediting the delivery of life-changing therapy to trial ...

Compared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda can cut the time spent in ...

Clinical trial solutions provider WCG has launched the new SaaS technology, ClinSphere Total Feasibility, to enhance site ...

MedUni Vienna physicians Daniel Aletaha and Josef Smolen have developed the Preferrix digital tool to enhance clinical trial ...

Childhood obesity is a formidable public health challenge in the US, posing a risk of various downstream health issues for ...

Acumen Pharmaceuticals has concluded enrolment for the Phase II ALTITUDE-AD trial of sabirnetug for treating patients with ...

Despite missing its primary endpoint, Equillium is pushing ahead with itolizumab citing its complete response by day 99.

Epicrispr has raised $68m in the initial close of its Series B financing round to commence the clinical trial of EPI-321 for ...

Lipocine has announced the commencement of a Phase III clinical trial of LPCN 1154, being developed for postpartum depression ...

J&J's Rybrevant and Lazcluze combination reduced the risk of death by 25% compared to AstraZeneca’s Tagrisso in NSCLC.

KalVista Pharmaceuticals has finished enrolling subjects in its KONFIDENT-KID trial of sebetralstat for hereditary angioedema ...

The randomised trial saw more than half of patients dosed with Sunosi achieving clinical response to the therapy used to ...